2nd Global Conference on Addiction and Psychiatry (GAP 2027)

 

The 2nd Global Conference on Addiction and Psychiatry (GAP 2027) will take place on September 22–24, 2027, in Barcelona, Spain, and online. This international conference aims to bring together researchers, psychiatrists, psychologists, healthcare professionals, academicians, scientists, and experts to share knowledge, discuss emerging developments, and explore innovative approaches in addiction treatment and mental healthcare.

GAP 2027 will provide a platform for scientific exchange, professional collaboration, and discussions on current challenges and future directions in addiction and psychiatry.

About GAP 2027

Addiction and psychiatric disorders continue to present significant challenges to individuals, families, healthcare professionals, and communities worldwide. Advances in research, early intervention, evidence-based treatment, and integrated mental health services are essential to improving outcomes and supporting recovery.

GAP 2027 aims to encourage discussions on innovative research, clinical practices, prevention strategies, and patient-centered approaches to addiction and psychiatric care.

Key Topics of the Conference

The conference welcomes research contributions and presentations related to:

  • Addiction Medicine and Substance Use Disorders

  • Psychiatry and Mental Health

  • Behavioral Addictions

  • Neuropsychiatry and Neuroscience

  • Psychology and Psychotherapy

  • Dual Diagnosis and Co-occurring Disorders

  • Addiction Prevention, Treatment, and Recovery

  • Mental Health Interventions and Rehabilitation

  • Public Mental Health and Community-Based Care

  • Emerging Research and Innovations in Psychiatric Care

Why Participate in GAP 2027?

GAP 2027 offers opportunities to:

  • Present research findings and clinical experiences.

  • Exchange ideas with international researchers and healthcare professionals.

  • Explore emerging developments in addiction and psychiatric care.

  • Build professional networks and research collaborations.

  • Participate in scientific discussions with experts from different disciplines.

Call for Abstracts

Researchers, clinicians, academicians, students, and healthcare professionals are invited to submit abstracts for consideration for oral and poster presentations.

Participants interested in sharing their research and contributing to scientific discussions are encouraged to visit the official conference website for submission guidelines and participation information.

Submit your abstract: https://addiction.irisscientificgroup.com/abstract-submission

Conference Details

Conference: 2nd Global Conference on Addiction and Psychiatry (GAP 2027)

Dates: September 22–24, 2027

Location: Barcelona, Spain & Online

Format: Hybrid Conference

Venue: Hotel Alimara Barcelona

Official Website: https://addiction.irisscientificgroup.com/

Join the Conversation

Be part of the global discussion on addiction research, psychiatric care, mental health, and recovery. GAP 2027 welcomes contributions that support scientific advancement, professional collaboration, and improved approaches to mental healthcare.

Visit the official website for further information about the conference, abstract submission, and participation opportunities.

GAP 2027 — Connecting Research, Advancing Care, Supporting Recovery.

#GAP2027 #AddictionPsychiatry #MentalHealth #AddictionResearch #PsychiatryConference #GlobalConference

Comments

Post a Comment

Popular posts from this blog

First Round Call for Abstracts & Early Registration – GAP 2026

Image
The Global Conference on Addiction and Psychiatry (GAP 2026) invites researchers, clinicians, and professionals to participate in this prestigious international event, taking place August 24–26, 2026 at the Sheraton Skyline Hotel London Heathrow, United Kingdom . Important Deadlines: First Round Abstract Submission Ends: April 29, 2026 Early Registration Closes: April 30, 2026 This is your opportunity to contribute to meaningful discussions and showcase your research on a global stage. Why Attend GAP 2026? Present innovative research in addiction and psychiatry Network with international experts and peers Gain insights into the latest advancements in mental health Important Links: Abstract Submission: https://addiction.irisscientificgroup.com/abstract-submission Registration: https://addiction.irisscientificgroup.com/register Conference Website: https://addiction.irisscientificgroup.com/ ⏳ With deadlines fast approaching, we encourage all interested participants to act now and secu...
Read more

🧠 Abstract Submissions Closing Soon – Final Call for GAP 2026!

Image
 The countdown has begun for the Global Conference on Addiction and Psychiatry (GAP 2026) , and this is your last opportunity to submit your abstract and secure your presentation slot before the conference begins. 📅 Conference Dates: August 24–26, 2026 📍 Conference Venue: Sheraton Skyline Hotel London Heathrow, Heathrow Airport, Bath Rd, London, United Kingdom UB3 5BP 🌐 Mode: Hybrid (In-person & Online) As a leading international platform in psychiatry, addiction medicine, behavioral science, recovery research, and mental health innovation , GAP 2026 will unite psychiatrists, psychologists, addiction specialists, neuroscientists, therapists, counselors, and healthcare researchers from around the world. This is your opportunity to showcase your latest work in substance use disorders, relapse prevention, behavioral therapies, neuropsychiatry, trauma care, digital mental health, recovery science, and psychiatric innovations . 👉 Submit your abstract now:  https://addi...
Read more

Bridging Depression and Addiction: From Self-Medication to Resilience – Key Insights from GAP 2026

Image
 The upcoming Global Conference on Addiction and Psychiatry (GAP 2026) will feature an insightful presentation by Dr. Eva Ein-Eli , highlighting the complex relationship between depression and substance use disorders (SUDs). This session brings together neuroscience, psychology, and clinical expertise to offer practical, real-world solutions. Title: Depression and substance use disorders: From self medication to resilience integrating clinical practice and neuroscientific insights 🔍 Key Highlights of the Presentation High Comorbidity & Clinical Burden Strong overlap between depression and substance use disorders Increased suicide risk and poorer treatment outcomes Self-Medication Hypothesis Substance use as a coping mechanism for emotional pain Addiction linked to attempts at managing anxiety, trauma, and distress Neuroscientific Mechanisms Dysregulated dopamine reward system Overactive stress response (HPA axis) driving craving and anhedonia Psychosocial Factors Impact of ea...
Read more